rhinitis%20-%20allergic
RHINITIS - ALLERGIC
Allergic rhinitis is a symptomatic disorder of the nose secondary to IgE-mediated inflammation of the nasal membranes induced after exposure to allergens.
Major symptoms include nasal itching, watery rhinorrhea, nasal obstruction/congestion, sneezing and postnasal drainage.
Other symptoms include headache, conjunctival symptoms, eye pruritus, impaired smell and morning cough.
Symptoms can reverse spontaneously with or without treatment.

Rhinitis%20-%20allergic Signs and Symptoms

Definition

Rhinitis

  • Inflammation of the nasal lining membranes

 Allergic Rhinitis

  • A symptomatic disorder of the nose secondary to IgE-mediated inflammation of the nasal membranes induced after exposure to allergens

Signs and Symptoms

Major Symptoms

  • Nasal itching
  • Watery rhinorrhea
  • Nasal obstruction/congestion
  • Sneezing
  • Postnasal drainage

Other Symptoms

  • Headache
  • Conjunctival symptoms, eye pruritus
  • Impaired smell
  • Morning cough
  • Sleep problems/excessive daytime sleepiness/sleep-disordered breathing or obstructive sleep apnea

Symptoms can reverse spontaneously with or without treatment

Pathophysiology

  • There may be various diatheses for allergic rhinitis sensitization but the most important mechanisms are:
    • Genetic factors 
    • Production of IgE antibody 
  • Most allergic rhinitis are caused by inhalation antigens such as:
    • Dermatophagoides (antigen in house dust) - most common
    • Pollens (eg trees, grasses and weeds) - most common
    • Fungi
    • Pets
  • Two phase reactions:
    • Early phase reaction happens when histamine and leukotrienes are released from mast cells and irritate the sensory nerve endings and blood vessels of the nasal mucosa
      • This irritation causes sneezing, rhinorrhea (watery), nasal mucosal swelling or blockage 
    • Late phase reaction happens when inflammatory cells like activated eosinophils infiltrate the nasal mucosa that is exposed to these antigens
      • Seen 6-10 hours after the exposure to antigens
      • Causes mucosal swelling
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Respirology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Pearl Toh, 21 Sep 2020
Early and sustained treatments with simplified regimen are the key to achieving good asthma control, said experts during a presentation at the ERS 2020 Congress.
Roshini Claire Anthony, 6 days ago

Treatment with the DPP 1* inhibitor brensocatib prolonged time to exacerbation and reduced exacerbation rates in patients with non-cystic fibrosis bronchiectasis, according to the phase II WILLOW** study presented at ERS 2020.

Pearl Toh, 06 Aug 2020
A fixed-dose triple therapy of ICS, LAMA, and LABA* is superior to dual therapies of either LAMA-LABA or ICS-LABA for controlling exacerbations in patients with moderate-to-very-severe COPD**, according to the large ETHOS*** trial.